Top 10 Companies in the (S)-(-)-1,2,4-Butanetriol (CAS No. 42890-76-6) Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

The Global (S)-(-)-1,2,4-Butanetriol (CAS No. 42890-76-6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4 % during the forecast period.

(S)-(-)-1,2,4-Butanetriol is a chiral triol compound with the molecular formula C₄H₁₀O₃, characterized by its specific levorotatory optical activity. It serves as a critical chiral building block and intermediate in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals. The compound finds application in the production of 1,2,4-butanetriol trinitrate (BTTN), a plasticizer used in energetic materials, as well as in the development of nucleoside analogs and other biologically active molecules.

The market is witnessing steady growth driven by rising demand for enantiopure intermediates in pharmaceutical synthesis and increasing adoption across fine chemical manufacturing. Furthermore, advancements in asymmetric synthesis and biocatalytic production routes have enhanced the cost‑effectiveness and scalability of (S)-(-)-1,2,4-Butanetriol manufacturing. Cambrex Corporation, TCI Chemicals, and Sigma‑Aldrich (Merck KGaA) are among the notable suppliers operating in this space with established portfolios of chiral specialty chemicals.

(S)-(-)-1,2,4-Butanetriol (CAS No. 42890-76-6) Market – View in Detailed Research Report

---

🔟 1. Merck KGaA (Germany)

Headquarters: Darmstadt, Germany
Key Offering: High‑purity chiral triols, custom synthesis services

Merck KGaA, through its MilliporeSigma division, leads the market with robust production capabilities for enantiomerically pure (S)-(-)-1,2,4‑Butanetriol. Its global supply chain and ongoing investments in asymmetric synthesis technologies ensure consistent quality and rapid delivery to pharmaceutical and research customers.

Sustainability & Growth Initiatives:

• Investments in green chemistry and renewable feedstock utilization
• ISO 9001 and GMP certification across all manufacturing sites
• Strategic partnerships with pharma R&D hubs for joint development

---

9️⃣ 2. Tokyo Chemical Industry (TCI) Co., Ltd. (Japan)

Headquarters: Tokyo, Japan
Key Offering: Catalog chemicals, custom manufacturing, chiral intermediates

TCI’s expertise in catalog chemicals and custom manufacturing services makes it a preferred supplier for academic and industrial clients seeking high‑purity (S)-(-)-1,2,4‑Butanetriol. Its advanced catalytic processes enable scalable production with low environmental impact.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recycling
• Commitment to carbon neutrality by 2030
• Collaboration with universities for asymmetric catalyst development

---

8️⃣ 3. Biosynth AG (Switzerland)

Headquarters: Zurich, Switzerland
Key Offering: Chiral building blocks, biocatalytic solutions

Following its acquisition of Carbosynth, Biosynth AG has expanded its portfolio of chiral intermediates, including (S)-(-)-1,2,4‑Butanetriol. The company leverages its expertise in enzymatic synthesis to provide high‑purity products at competitive prices.

Sustainability & Growth Initiatives:

• Biocatalytic production from renewable sugars
• ISO 14001 environmental management system
• Investment in scalable fermentation platforms

---

7️⃣ 4. Carbosynth Ltd. (UK)

Headquarters: London, United Kingdom
Key Offering: Custom synthesis, chiral intermediates

Carbosynth provides bespoke synthesis services for pharmaceutical intermediates, including (S)-(-)-1,2,4‑Butanetriol. Its flexible production model supports both small‑batch academic projects and large‑scale industrial demands.

Sustainability & Growth Initiatives:

• Adoption of green solvents and energy‑efficient processes
• GMP compliant manufacturing lines
• Partnerships with biotech start‑ups for process optimization

---

6️⃣ 5. Combi‑Blocks Inc. (USA)

Headquarters: San Diego, California, USA
Key Offering: Research‑grade chiral chemicals, custom synthesis

Combi‑Blocks specializes in research‑grade quantities of chiral intermediates, providing (S)-(-)-1,2,4‑Butanetriol with high enantiomeric excess for academic and CRO use. Its state‑of‑the‑art synthesis facilities emphasize safety and environmental stewardship.

Sustainability & Growth Initiatives:

• Zero‑waste production protocols
• Carbon‑offset initiatives for transportation
• Collaborations with university labs for green chemistry projects

---

5️⃣ 6. Enamine LLC (Ukraine)

Headquarters: Kyiv, Ukraine
Key Offering: Scalable manufacturing, chiral intermediates

Enamine offers scalable production of (S)-(-)-1,2,4‑Butanetriol, supporting both large‑volume pharmaceutical manufacturing and high‑purity research needs. Its manufacturing sites adhere to ISO 9001 and GMP standards.

Sustainability & Growth Initiatives:

• Renewable energy integration in production plants
• Water‑recycling systems to reduce consumption
• Investment in digital process monitoring

---

4️⃣ 7. Oakwood Chemical (USA)

Headquarters: New York, New York, USA
Key Offering: Custom synthesis, chiral building blocks

Oakwood Chemical provides tailored synthesis solutions for complex chiral intermediates, including (S)-(-)-1,2,4‑Butanetriol, with a focus on meeting stringent regulatory requirements for pharmaceutical use.

Sustainability & Growth Initiatives:

• Implementation of green chemistry principles across all processes
• ISO 14001 certification for environmental management
• Strategic alliances with pharma companies for joint R&D

---

3️⃣ 8. Hairui Industries Co., Ltd. (China)

Headquarters: Guangzhou, China
Key Offering: Cost‑effective chiral intermediates, large‑scale production

Hairui Industries leverages its extensive manufacturing network to deliver high‑purity (S)-(-)-1,2,4‑Butanetriol at competitive prices, targeting the rapidly growing Asian pharmaceutical market.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for synthesis
• Energy‑efficient production lines
• Participation in regional green chemistry initiatives

---

2️⃣ 9. Pharmaffiliates Analytics & Synthetics (India)

Headquarters: Pune, India
Key Offering: Custom synthesis, chiral intermediates for pharma

Pharmaffiliates provides customized synthesis of (S)-(-)-1,2,4‑Butanetriol for Indian and global pharmaceutical clients, emphasizing quality and rapid turnaround.

Sustainability & Growth Initiatives:

• Use of bio‑based solvents and reagents
• ISO 9001 and GMP compliant facilities
• Collaboration with research institutes for process innovation

---

1️⃣ 10. Apollo Scientific Ltd. (UK)

Headquarters: Bristol, United Kingdom
Key Offering: Research‑grade chiral intermediates, custom synthesis

Apollo Scientific delivers high‑purity (S)-(-)-1,2,4‑Butanetriol for academic and industrial research, supporting the development of novel therapeutics.

Sustainability & Growth Initiatives:

• Green chemistry training programs for staff
• Waste‑minimization protocols in synthesis
• Engagement with EU green funding schemes

---

Download FREE Sample Report: (S)-(-)-1,2,4-Butanetriol (CAS No. 42890-76-6) Market – View in Detailed Research Report

Get Full Report: (S)-(-)-1,2,4-Butanetriol (CAS No. 42890-76-6) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (S)-(-)-1,2,4-Butanetriol Market

The (S)-(-)-1,2,4‑Butanetriol market is poised for continued expansion, driven by the dual demand from pharmaceutical development and energetic materials. The shift toward green chemistry and biocatalytic production routes is expected to lower costs and improve scalability, while stringent regulatory frameworks for dual‑use chemicals will shape supply chain strategies. Market leaders will focus on innovation in asymmetric catalysis, renewable feedstock integration, and digital supply‑chain transparency to maintain competitive advantage.

📈 Key Trends Shaping the Market:

• Rapid adoption of asymmetric synthesis technologies in drug discovery
• Growth of bio‑based production platforms leveraging engineered microbes
• Increasing regulatory emphasis on dual‑use chemical controls
• Expansion of specialty chemical applications in agrochemicals and polymer additives

🔮 Future Trends:

• Emergence of integrated bioprocessing facilities for chiral polyols
• Development of modular synthesis units for rapid scale‑up
• Enhanced collaboration between pharma and fine‑chemical manufacturers for co‑development
• Greater focus on ESG criteria in procurement and supply‑chain management